Company news
Clover Biopharmaceuticals Ltd. news in 2024
Clover Biopharmaceuticals Ltd.'s news releases, calls and decks from 2024, newest first.
Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY
October 28, 2024
Clover Announces Positive Preliminary Phase Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults
June 19, 2024
Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults
June 18, 2024
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort
April 8, 2024